Zimbabwe has rejected a major US health deal worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on sensitive data.
This move became public following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson has since explained that the United States was seeking biological samples for research and profit but was not willing to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more dialogue to find a deal acceptable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement following concerns were raised about the security of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
According to statements, 16 African countries have to date agreed to these new agreements, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research with no certainty that the final treatments would be accessible to our population should a new disease outbreak emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This system is designed to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further dialogue with our American counterparts on how future co-operation could be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations should continue given that much of the nation's HIV programmes depended on foreign aid.
"If specific concerns arise, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it commented.
The situation highlights the continuing debate between accepting vital international aid and safeguarding national sovereignty in an ever more data-driven world.